» Articles » PMID: 34208417

NMR-Based Metabolomics in Investigation of the Radiation Induced Changes in Blood Serum of Head and Neck Cancer Patients and Its Correlation with the Tissue Volumes Exposed to the Particulate Doses

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2021 Jul 2
PMID 34208417
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In the present study, we analyze the nuclear magnetic resonance (NMR) blood serum metabolic profiles of 106 head and neck squamous cell carcinoma (HNSCC) patients during radio (RT) and concurrent radio-chemotherapy (CHRT). Four different fractionation schemes were compared. The blood samples were collected weekly, from the day before the treatment until the last week of CHRT/RT. The NMR spectra were acquired on A Bruker 400 MHz spectrometer at 310 K and analyzed using multivariate methods. Seven metabolites were found significantly to be altered solely by radiotherapy: N-acetyl-glycoprotein (NAG), N-acetylcysteine, glycerol, glycolate and the lipids at 0.9, 1.3 and 3.2 ppm. The NMR results were correlated with the tissue volumes receiving a particular dose of radiation. The influence of the irradiated volume on the metabolic profile is weak and mainly limited to sparse correlations with the inflammatory markers, creatinine and the lymphocyte count in RT and the branched-chain amino-acids in CHRT. This is probably due to the optimal planning and delivery of radiotherapy improving sparing of the surrounding normal tissues and minimizing the differences between the patients (caused by the tumor location and size).

Citing Articles

Uracil as a biomarker for spatial pyrimidine metabolism in the development of gingivobuccal oral squamous cell carcinoma.

Shaikh S, Basu S, Bag S, Chatterjee A, Datta S, Banerjee D Sci Rep. 2024; 14(1):11609.

PMID: 38773214 PMC: 11109148. DOI: 10.1038/s41598-024-62434-z.


Metabolite Biomarkers of Prolonged and Intensified Pain and Distress in Head and Neck Cancer Patients Undergoing Radio- or Chemoradiotherapy by Means of NMR-Based Metabolomics-A Preliminary Study.

Boguszewicz L, Heyda A, Ciszek M, Bielen A, Skorupa A, Mrochem-Kwarciak J Metabolites. 2024; 14(1).

PMID: 38248863 PMC: 10819132. DOI: 10.3390/metabo14010060.


Metabolomic Insight into Implications of Induction Chemotherapy Followed by Concomitant Chemoradiotherapy in Locally Advanced Head and Neck Cancer.

Boguszewicz L, Bielen A, Ciszek M, Skorupa A, Mrochem-Kwarciak J, Skladowski K Int J Mol Sci. 2024; 25(1).

PMID: 38203359 PMC: 10779362. DOI: 10.3390/ijms25010188.


The Metabolic Footprint of Systemic Effects in the Blood Caused by Radiotherapy and Inflammatory Conditions: A Systematic Review.

Jelonek K, Mrowiec K, Gabrys D, Widlak P Metabolites. 2023; 13(9).

PMID: 37755280 PMC: 10534379. DOI: 10.3390/metabo13091000.


Unsupervised Hierarchical Clustering of Head and Neck Cancer Patients by Pre-Treatment Plasma Metabolomics Creates Prognostic Metabolic Subtypes.

Eldridge R, Qin Z, Saba N, Houser M, Hayes D, Miller A Cancers (Basel). 2023; 15(12).

PMID: 37370794 PMC: 10296258. DOI: 10.3390/cancers15123184.


References
1.
Jensen M, Chandramouli V, Schumann W, Ekberg K, Previs S, Gupta S . Sources of blood glycerol during fasting. Am J Physiol Endocrinol Metab. 2001; 281(5):E998-1004. DOI: 10.1152/ajpendo.2001.281.5.E998. View

2.
Otvos J, Shalaurova I, Wolak-Dinsmore J, Connelly M, Mackey R, Stein J . GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. Clin Chem. 2015; 61(5):714-23. DOI: 10.1373/clinchem.2014.232918. View

3.
Huang J, Yuan X, Pang Q, Zhang H, Yu J, Yang B . Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells. Drug Des Devel Ther. 2018; 12:2223-2231. PMC: 6052925. DOI: 10.2147/DDDT.S163595. View

4.
Santa Cruz O, Tsoutsou P, Castella C, Khanfir K, Anchisi S, Bouayed S . Locoregional Control and Toxicity in Head and Neck Carcinoma Patients following Helical Tomotherapy-Delivered Intensity-Modulated Radiation Therapy Compared with 3D-CRT Data. Oncology. 2018; 95(2):61-68. DOI: 10.1159/000489217. View

5.
Tardiolo G, Bramanti P, Mazzon E . Overview on the Effects of -Acetylcysteine in Neurodegenerative Diseases. Molecules. 2018; 23(12). PMC: 6320789. DOI: 10.3390/molecules23123305. View